Kristin Yarema Net Worth & Insider Trades
Kristin Yarema - Chief Commercial Officer, Atara Biotherapeutics, Inc
What is Kristin Yarema's Net Worth?
The current estimated net worth of Atara Biotherapeutics, Inc's Chief Commercial Officer, Kristin Yarema, is estimated to be about $745.35K . Kristin Yarema owns about 125,882 units of Atara Biotherapeutics, Inc common stock. In the last 2 years at Atara Biotherapeutics, Inc, Kristin Yarema has sold an estimated value of $11.07K worth.
What is Kristin Yarema's Past Insider Trading?
Kristin Yarema's largest purchase order was 34,354 units , worth over $500.37K on June 15, 2021. Kristin Yarema's largest sale order was 761 units , worth over $11.07K on May 20, 2021. In total, Kristin Yarema has made about 6 transactions over 2 years of their time at Atara Biotherapeutics, Inc. Kristin Yarema usually trades in March, with the busiest year in 2021.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kristin Yarema
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What was Kristin Yarema's Salary in 2020?
As Chief Commercial Officer of Atara Biotherapeutics, Inc, Kristin Yarema has a total base salary of $368,308 . Kristin Yarema received compensation valued at about $2,436,407 in 2020 after becoming Chief Commercial Officer. The vast majority of their compensation came in the form of a bonus of $147,995 , stock awards of $668,250 , option awards of $1,067,484 , and other compensation of $184,370 .
What is Kristin Yarema's' Mailing Address?
- Mailing address is C/o Atara Biotherapeutics, Inc. 611 Gateway Blvd., Suite 900 South San Francisco CA 94080 CA
Atara Biotherapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Pascal Touchon, D.V.M. | 2020 | $654,857 | $422,500 | $2,235,600 | $1,959,208 | $13,662 | $5,285,827 |
Pascal Touchon, D.V.M. | 2019 | $319,327 | $334,791 | $2,861,712 | $3,049,718 | $71,760 | $6,637,307 |
Jakob Dupont, M.D. | 2020 | $319,231 | $143,346 | $443,075 | $1,757,296 | $133,297 | $2,796,245 |
Utpal Koppikar | 2020 | $460,947 | $187,032 | $885,431 | $597,073 | $7,470 | $2,137,953 |
Utpal Koppikar | 2019 | $439,875 | $155,606 | $1,034,714 | $909,080 | $895 | $2,540,170 |
Utpal Koppikar | 2018 | $240,289 | $189,771 | $1,903,500 | $1,886,325 | $398 | $4,220,282 |
Joseph Newell | 2020 | $466,055 | $203,435 | $1,033,965 | $566,713 | $895 | $2,251,063 |
Joseph Newell | 2019 | $390,000 | $155,208 | $1,240,675 | $932,390 | $895 | $2,719,167 |
Joseph Newell | 2018 | $365,000 | $155,490 | $895,000 | $1,060,710 | $16,092 | $2,492,292 |
Kristin Yarema, Ph.D. | 2020 | $368,308 | $147,995 | $668,250 | $1,067,484 | $184,370 | $2,436,407 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1604464/000156459021020128/atra-def14a_20210608.htm
What are Atara Biotherapeutics, Inc's Past Insider Trades?
Atara Biotherapeutics, Inc's most recent insider trade came on August 18, 2023 by Eric J Hyllengren who sold 8,186 units worth $13.53K . In the last 9 years, insiders at Atara Biotherapeutics, Inc have sold an estimated value of $73.66M and bought an estimated value of $10.47M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Isaac E Ciechanover, Chief Executive Officer, Christopher Haqq, EVP, and Joe Newell, Chief Operations Officer .
Atara Biotherapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |